Results 111 to 120 of about 166,859 (297)

Review of Pharmacological treatments of Psoriasis

open access: yes, 2018
This work summarizes the general characteristic of psoriasis in terms of risk factors, epidemiology, clinical presentation, pathophysiology, diagnosis and treatment.hbkáltalános orvosangolegységes ...
Karmon, Idan
core  

Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris [PDF]

open access: yes, 2008
Background: Psoriasis is a chronic relapsing disorder which is influenced by various external factors. Korean psoriasis vulgaris are characterized by smaller sized plaques than those of Western population and this type of psoriasis was reported to be ...
유욱
core  

Transfersomes with core and surface‐loaded NF‐κB p65 siRNA for enhanced transdermal transfection and effective treatment of psoriasis

open access: yesBMEMat, EarlyView.
TCPL, a transfersome with Tween 80 and PEI, enables efficient transdermal siNF‐κB delivery, resolving PEI's toxicity issue. It promotes lysosomal escape and effective transfection, silences NF‐κB, modulates immunity, and inhibits angiogenesis, alleviating psoriasis. With good biocompatibility, TCPL holds strong clinical translation potential. Schematic
Hui Xing   +6 more
wiley   +1 more source

COVID-19 in patients with psoriasis: A Latin American case series

open access: yesJAAD International, 2021
Isabela Campo-Slebi, MD   +7 more
doaj   +1 more source

Statin Use and Psoriasis Severity

open access: yes, 2010
Background Inflammation plays a key role in psoriasis. Statins reduce inflammatory markers. However, data in the literature are limited regarding the effect of statins in psoriasis patients.
Perry, Adam   +7 more
core   +1 more source

Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Genetic variation contributes substantially to interindividual and interpopulation differences in drug response, yet most pharmacogenomic studies remain biased toward European populations. Here, we systematically assessed pharmacogenomic variation across East Asians (EAS) and Europeans (EUR) using public genomic datasets and investigated the potential ...
Sihan Chen, Hongpu Chen, Shuhua Xu
wiley   +1 more source

Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis

open access: yesFrontiers in Immunology
IntroductionPsoriasis is a T cell-mediated inflammatory skin disease, and biologics have demonstrated promising efficacy. However, some patients remain dissatisfied with early therapeutic outcomes.
Nan Yang   +23 more
doaj   +1 more source

A psoriasis modern terápiás lehetőségei

open access: yes, 2018
A pikkelysömör (psoriasis) egy igen gyakori, krónikus lefolyású, nem fertőző, immunológiai gyulladás által kiváltott bőrbetegség. Legfőbb jellemzője a bőrfelszínen megjelenő vörös színű, fehéren hámló, több centiméter nagyságú papulák és plakkok ...
Fábián, Fiona
core  

Radiolabeled Coordination Polymer‐Loaded Microneedles for Synergistic Melanoma Brachytherapy–Immunotherapy via STING Activation and Pyroptosis

open access: yesExploration, EarlyView.
We developed a dissolvable microneedle patch that locally delivers a radiolabeled coordination polymer designed to simultaneously destroy tumor cells and stimulate antitumor immunity through STING activation and pyroptosis. This strategy significantly inhibited melanoma growth and improved the effectiveness of immune checkpoint therapy, highlighting a ...
Pian Yu   +12 more
wiley   +1 more source

Psoriasis terápiája, ápolása, gondozása osztályunkon

open access: yes, 2016
Szakdolgozatomban a psoriasis bőrbetegséget szeretném bemutatni, illetve több oldalról megközelíteni, hiszen egy nagyon komplex összetevőjű kórképről van szó, melynek kialakulásában a genetikai, immunológiai, életmódbeli és pszichés hatások együttes ...
Hegyi-Kecsmár, Diána
core  

Home - About - Disclaimer - Privacy